Drug Profile
Ondansetron oral film - APR Applied Pharma Research/Labtec
Alternative Names: Ondansetron RapidFilm; SetofilmLatest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator Applied Pharma Research; Labtec
- Developer APR Applied Pharma Research; tesa Labtec
- Class Anti-inflammatories; Antiemetics; Antipsychotics; Carbazoles; Drug withdrawal therapies; Imidazoles; Irritable bowel syndrome therapies; Obesity therapies; Small molecules; Smoking cessation therapies
- Mechanism of Action Serotonin 3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Chemotherapy-induced nausea and vomiting; Postoperative nausea and vomiting; Radiotherapy-induced nausea and vomiting
Highest Development Phases
- Marketed Chemotherapy-induced nausea and vomiting; Postoperative nausea and vomiting; Radiotherapy-induced nausea and vomiting
Most Recent Events
- 01 Aug 2014 TopoTarget has merged with BioAlliance Pharma to form Onxeo SA
- 31 May 2013 Launched for Chemotherapy induced nausea and vomiting in European Union (PO)
- 31 May 2013 Launched for Postoperative nausea and vomiting in European Union (PO)